JP2024542142A5 - - Google Patents
Info
- Publication number
- JP2024542142A5 JP2024542142A5 JP2024526902A JP2024526902A JP2024542142A5 JP 2024542142 A5 JP2024542142 A5 JP 2024542142A5 JP 2024526902 A JP2024526902 A JP 2024526902A JP 2024526902 A JP2024526902 A JP 2024526902A JP 2024542142 A5 JP2024542142 A5 JP 2024542142A5
- Authority
- JP
- Japan
- Prior art keywords
- bispecific antibody
- mutation
- region
- mutations
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2115925.6 | 2021-11-05 | ||
| GB202115925 | 2021-11-05 | ||
| GB2204539.7 | 2022-03-30 | ||
| GBGB2204539.7A GB202204539D0 (en) | 2022-03-30 | 2022-03-30 | Novel peptides |
| GBGB2212801.1A GB202212801D0 (en) | 2022-09-02 | 2022-09-02 | Novel peptides |
| GB2212801.1 | 2022-09-02 | ||
| PCT/EP2022/080860 WO2023079101A2 (en) | 2021-11-05 | 2022-11-04 | Novel polypeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542142A JP2024542142A (ja) | 2024-11-13 |
| JP2024542142A5 true JP2024542142A5 (cg-RX-API-DMAC7.html) | 2025-11-13 |
Family
ID=84329469
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526902A Pending JP2024542142A (ja) | 2021-11-05 | 2022-11-04 | 新規ポリペプチド |
| JP2024526901A Pending JP2024543043A (ja) | 2021-11-05 | 2022-11-04 | 新規ペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526901A Pending JP2024543043A (ja) | 2021-11-05 | 2022-11-04 | 新規ペプチド |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US20260001961A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4426733A2 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2024542142A (cg-RX-API-DMAC7.html) |
| KR (2) | KR20240099410A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022381977A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3237463A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL312556A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024005508A (cg-RX-API-DMAC7.html) |
| WO (2) | WO2023079102A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20260001961A1 (en) * | 2021-11-05 | 2026-01-01 | Alligator Bioscience Ab | Novel polypeptides |
| JP2026515781A (ja) * | 2023-04-13 | 2026-05-19 | アリゲーター・バイオサイエンス・アーベー | 併用療法 |
| CN117924468B (zh) * | 2023-12-08 | 2024-09-20 | 南京大学 | 一种靶向登革热病毒ns1蛋白纳米抗体的制备方法和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| SE459005B (sv) | 1985-07-12 | 1989-05-29 | Aake Rikard Lindahl | Saett att framstaella sfaeriska polymerpartiklar |
| CA2192782C (en) | 1995-12-15 | 2008-10-14 | Nobuyuki Takechi | Production of microspheres |
| LT2691417T (lt) | 2011-03-29 | 2018-10-25 | Roche Glycart Ag | Antikūno fc variantai |
| GB201115280D0 (en) * | 2011-09-05 | 2011-10-19 | Alligator Bioscience Ab | Antibodies, uses and methods |
| CA2980189A1 (en) * | 2015-04-24 | 2016-10-27 | Genentech, Inc. | Multispecific antigen-binding proteins |
| CA3049791A1 (en) * | 2017-01-27 | 2018-08-02 | Silverback Therapeutics, Inc. | Tumor targeting conjugates and methods of use thereof |
| EP3898681A2 (en) * | 2018-12-17 | 2021-10-27 | Alligator Bioscience AB | Polypeptides |
| GB201820556D0 (en) | 2018-12-17 | 2019-01-30 | Alligator Bioscience Ab | Novel polypeptides |
| AU2020357944A1 (en) * | 2019-09-30 | 2022-03-31 | Adimab, Llc | CH1 domain variants engineered for preferential light chain pairing and multispecific antibodies comprising the same |
| EP4048701A4 (en) | 2019-10-23 | 2024-05-29 | Lyvgen Biopharma Holdings Limited | Anti-cd40 binding molecules and bi-specific antibodies comprising such |
| KR20220147583A (ko) * | 2020-01-09 | 2022-11-03 | 바이오뮤넥스 파마슈티컬스 | Mait 및 종양 세포 둘 모두에 결합하는 다중특이적 항체 |
| US20260001961A1 (en) * | 2021-11-05 | 2026-01-01 | Alligator Bioscience Ab | Novel polypeptides |
-
2022
- 2022-11-04 US US18/703,623 patent/US20260001961A1/en active Pending
- 2022-11-04 IL IL312556A patent/IL312556A/en unknown
- 2022-11-04 WO PCT/EP2022/080861 patent/WO2023079102A2/en not_active Ceased
- 2022-11-04 CA CA3237463A patent/CA3237463A1/en active Pending
- 2022-11-04 MX MX2024005508A patent/MX2024005508A/es unknown
- 2022-11-04 KR KR1020247018489A patent/KR20240099410A/ko active Pending
- 2022-11-04 JP JP2024526902A patent/JP2024542142A/ja active Pending
- 2022-11-04 EP EP22800717.5A patent/EP4426733A2/en active Pending
- 2022-11-04 EP EP22822279.0A patent/EP4426738A2/en active Pending
- 2022-11-04 US US17/980,751 patent/US11873348B2/en active Active
- 2022-11-04 AU AU2022381977A patent/AU2022381977A1/en active Pending
- 2022-11-04 WO PCT/EP2022/080860 patent/WO2023079101A2/en not_active Ceased
- 2022-11-04 JP JP2024526901A patent/JP2024543043A/ja active Pending
- 2022-11-04 KR KR1020247018934A patent/KR20240114794A/ko active Pending
-
2023
- 2023-11-13 US US18/507,736 patent/US12448465B2/en active Active
-
2025
- 2025-09-15 US US19/329,496 patent/US20260146107A1/en active Pending